The Diagnostics Accelerator and Target ALS Foundation Biomarker Discovery RFP

The Diagnostics Accelerator and Target ALS are joining forces to fund biomarker research targeting biomarkers that might be common to disease pathways or pathophysiologies in Alzheimer’s disease, FTD and ALS to facilitate biomarker discovery and validation. 

Projects will be funded via two mechanisms:

Option 1: As a grant through Target ALS Foundation

Option 2: As a mission-related investment from the Diagnostics Accelerator at the ADDF

Only collaborative projects will be funded. Each collaborative project must include two to four investigators with at least one based at a pharmaceutical/biotechnology company working around a common biomarker 

Funding: option 1 $300,000; option 2 $500,000

Duration: 3 years